Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 401–500 of 935
Arber, C., Villegas-Llerena, C., Toombs, J., Pocock, J. M., Ryan, N. S., Fox, N. C., Zetterberg, H., Hardy, J., & Wray, S. (2019) · Brain Communications · doi:10.1093/braincomms/fcz024 · Cited by 19
Factors targeting MED12 to drive tumorigenesis?
Bullerdiek, J., & Rommel, B. (2018) · F1000Research · doi:10.12688/f1000research.14227.1 · Cited by 19
Vaclová, T., Chakraborty, A., Sherwood, J. L., Ross, S. J., Carroll, D. K., Barrett, J. C., Downward, J., & de Bruin, E. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-06369-3 · Cited by 22
Ulaganathan, S., & Pitchaimani, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121918 · Cited by 25
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 20
New Insights of CRISPR Technology in Human Pathogenic Fungi
Román, E., Prieto, D., Alonso‐Monge, R., & Plá, J. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0183 · Cited by 19
Generation of Nonhuman Primate Model of Cone Dysfunction through In Situ AAV-Mediated CNGB3 Ablation
Lin, Q., Lv, J., Wu, K., Zhang, C.-J., Liu, Q., & Jin, Z. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.08.007 · Cited by 19
A Cas9-mediated adenosine transient reporter enables enrichment of ABE-targeted cells
Brookhouser, N., Nguyen, T., Tekel, S. J., Standage-Beier, K., Wang, X., & Brafman, D. A. (2020) · BMC Biology · doi:10.1186/s12915-020-00929-7 · Cited by 19
Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes
Armitage, L. H., Stimpson, S. E., Santostefano, K. E., Sui, L., Ogundare, S. O., Newby, B. N., Castro-Gutiérrez, R., Huber, M. K., Taylor, J. P., Sharma, P., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737276 · Cited by 20
FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
Caillaud, A., Lévêque, A., Thedrez, A., Girardeau, A., Canac, R., Bray, L., Baudic, M., Barc, J., Gaborit, N., Lamirault, G., et al. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101680 · Cited by 24
“As described previously, insertion of a molecular tag or single nucleotide mutation required a gRNA having a cutting site within 10 bp from the insertion point (Paquet et al., 2016).”
BackgroundInfluentialNext-generation mammalian genetics toward organism-level systems biology
Susaki, E. A., Ukai, H., & Ueda, H. R. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0015-2 · Cited by 21
CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
Rahman, S., Datta, M., Kim, J., & Jan, A. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.014 · Cited by 20
Optimizing homology-directed repair for gene editing: the potential of single-stranded DNA donors
Jin, Y.-Y., Zhang, P., & Liu, D. (2025) · Trends in Genetics · doi:10.1016/j.tig.2025.04.014 · Cited by 20
Tong, G., Izquierdo, P., & Raashid, R. A. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010027 · Cited by 18
“One recent study that explored the use of CRISPR/Cas9 in introducing mutations to study AD found that using this improved genomic editing technique they accurately and efficiently generated both homozygous and heterozygous dominant AD-causing mutations [78].”
BackgroundBase Editing in Human Cells to Produce Single‐Nucleotide‐Variant Clonal Cell Lines
Vásquez, C. A., Cowan, Q. T., & Komor, A. C. (2020) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.129 · Cited by 22
“…and homozygous knock-in clones with traditional genome editing methods is typically quite Vasquez et al. 33 of 38 Current Protocols in Molecular Biology inefficient or impossible without the use of “blocking mutations” (Paquet et al., 2016) or multiple clonal expansion steps (Kim et al., 2018).”
BackgroundMethodResultInfluentialSingh, S., & Ramakrishna, W. (2021) · 3 Biotech · doi:10.1007/s13205-021-03041-x · Cited by 23
Genetic therapies for neurological disorders
FitzPatrick, L., & Bird, A. P. (2021) · Human Genetics · doi:10.1007/s00439-021-02399-5 · Cited by 21
“Precise changes can be introduced into the genome using CRISPR/Cas9 if a homologous DNA repair template is supplied at the same time, permitting repair by the highfidelity homology-directed repair (HDR) pathway (Cong et al. 2013; Paquet et al. 2016).”
BackgroundGhosh, D., Chakravarti, R., Lenka, S. K., Gautam, A., Singh, R., Ravichandiran, V., & Roy, S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220117105531 · Cited by 18
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
Lau, C., Liang, Q., & Zhu, H. (2024) · Transgenic Research · doi:10.1007/s11248-024-00404-x · Cited by 20
“Two most common applications of CRISPR technology in genome editing are functional gene knock-out (Cho et al. 2013; Shalem et al. 2014) and gene knockin (Paquet et al. 2016; Sadhu et al. 2018).”
Modeling Cancer in the CRISPR Era
Ventura, A., & Dow, L. E. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050455 · Cited by 18
“…stem cell lines for disease modeling or to perform disease allele correction in primary patient-derived cells (Dever et al. 2016, Howden et al. 2015, H.L. Li et al. 2015, Paquet et al. 2016, Schwank et al. 2013, Soldner et al. 2016), including large chromosomal aberrations (Park et al. 2015).”
BackgroundAl-Ateeq, S., Ovchinnikov, D. A., Tracey, T. J., Whitworth, D. J., Al‐Rubaish, A. M., Al‐Ali, A. K., & Wolvetang, E. J. (2018) · APL Bioengineering · doi:10.1063/1.5048625 · Cited by 18
“HDR accuracy can theoretically be further improved by introducing a single nucleotide polymorphisms (SNP) in the protospacer adjacent motif (PAM) sequence at the binding site for one of the guides of the pair set, as shown by Paquet et al. (Paquet et al., 2016) for Cas9WT.”
BackgroundInfluentialHernandez, V. A., Carvajal‐Moreno, J., Papa, J. L., Shkolnikov, N., Li, J., Özer, H. G., Yalowich, J. C., & Elton, T. S. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.120.000173 · Cited by 18
“Neverthe-less, high editing efficiency requires gRNA targeting close to the intended mutation (Paquet et al., 2016; Liang et al., 2017).”
BackgroundAKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis
Sánchez-Vazquez, R., Martínez, P., & Blasco, M. A. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009410 · Cited by 19
“The ssODN was designed to change the Cas9 cleavage site to avoid re-cutting and to introduce a new restriction site for genotyping without altering the encoded amino acid sequence [43].”
MethodThe Role of Gene Editing in Neurodegenerative Diseases
Fan, H.-C., Chi, C.-S., Lee, Y.-J., Tsai, J., Lin, S., & Harn, H.-J. (2018) · Cell Transplantation · doi:10.1177/0963689717753378 · Cited by 23
Dannert, A., Klimmt, J., Gonçalves, C. C., Crusius, D., & Paquet, D. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102266 · Cited by 20
“For complete details on the use and execution of this protocol, please refer to Paquet et al.(1) and Weisheit et al.”
BackgroundMethodInfluentialSelf-citationModeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
Maurissen, T. L., Kawatou, M., López-Dávila, V., Minatoya, K., Yamashita, J. K., & Woltjen, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-52871-1 · Cited by 19
“Often, when targeting autosomal genes with CRISPR-Cas9 and single-strand oligonucleotide (ssODN) templates both alleles are edited, leading to homozygous mutations or heterozygous mutations with an undesirable insertion or deletion mutations (indels) on the second allele 5,30 .”
BackgroundDeep orange gene editing triggers temperature-sensitive lethal phenotypes in Ceratitis capitata
Sollazzo, G., Nikolouli, K., Gouvi, G., Aumann, R. A., Schetelig, M. F., & Bourtzis, K. (2024) · BMC Biotechnology · doi:10.1186/s12896-024-00832-x · Cited by 17
“…the mutation found in the wp tsl mutant strains while the second 75 (G > C; Ala838 > Ala838) and the third 72 (A > G; Gln837 > Gln837) are silent mutations to reduce the target sequence similarity after HDR and mutate the PAM site to prevent re-editing by the CRISPR/Cas9 machinery [88, 89].”
BackgroundArshad, S., Qadir, M. L., Hussain, N., Ali, Q., Han, S., & Ali, D. (2025) · Functional Plant Biology · doi:10.1071/fp24255 · Cited by 20
Sequential and counter-selectable cassettes for fission yeast
Amelina, H., Moiseeva, V., Collopy, L. C., Pearson, S. R., Armstrong, C. A., & Tomita, K. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0307-4 · Cited by 17
“This means that the designed DNA repair template will recombine only at the DSB site, and the substitution of the designed point mutation needs to be close to the DSB site [11].”
BackgroundA pipeline for characterization of novel Cas9 orthologs
Karvelis, T., Young, J. K., & Šikšnys, V. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.021 · Cited by 19
Kissling, L., Monfort, A., Swarts, D. C., Wutz, A., & Jínek, M. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.028 · Cited by 18
Kawai, K., Negoro, R., Ichikawa, M., Yamashita, T., Deguchi, S., Harada, K., Hirata, K., Takayama, K., & Mizuguchi, H. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.008 · Cited by 18
Kivrak, E., Pauzaite, T., Copeland, N. A., Hardy, J. G., Kara, P., Fırlak, M., Yardımcı, A. İ., Yılmaz, S., Palaz, F., & Özsöz, M. (2021) · Biosensors · doi:10.3390/bios11010017 · Cited by 17
“The use of ssODN is highly efficie t for introducing small mutations, including single point mutations, via HDR-based gene editing [25,34].”
MethodScheller, S. H., Rashad, Y., Saleh, F. M., Willingham, K., Reilich, A., Lin, D., Izadpanah, R., Alt, E., & Braun, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821190 · Cited by 18
“HDR, regardless of zygosity, is known to be a quite inefficient process (42, 53, 74).”
BackgroundGao, K., Zhang, X., Zhang, Z., Wu, X., Guo, Y., Fu, P., Sun, A., Peng, J., Zheng, J., Yu, P., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac676 · Cited by 18
A high efficiency precision genome editing method with CRISPR in iPSCs
Singh, A., Smedley, G. D., Rose, J.-G., Fredriksen, K., Zhang, Y., Li, L., & Yuan, S. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-60766-4 · Cited by 16
Decoding polygenic diseases: advances in noncoding variant prioritization and validation
Chin, I. M., Gardell, Z. A., & Corces, M. R. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.03.005 · Cited by 21
González-Gallego, J., Völgyi, K., Müller, S. A., Antesberger, S., Todorov, M. I., Malik, R., Grimalt-Mirada, R., Gonçalves, C. C., Schifferer, M., Kislinger, G., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02123-w · Cited by 24
“CRISPR–Cas9 editing was performed as described previously 65,66 , with modifications for ribonucleoprotein (RNP)-based DNA cleavage 67 no.”
Self-citationLackner, M., Helmbrecht, N., Pääbo, S., & Riesenberg, S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1254 · Cited by 19
“However, additional substitutions are commonly introduced in genome editing as ‘blocking mutations’ to prevent repeated cleavage of the target site (38).”
Sato, G. E., & Kuroda, K. (2023) · Microorganisms · doi:10.3390/microorganisms11041040 · Cited by 18
“In addition, DSBs can cause unintended mutations in target equences, even when the Cas9/gRNA complex is ccurately targeted to the desired sequ nce and HDR is p rformed using donor DNA [33,34] (Figure 2).”
BackgroundLi, H., Ding, Z., Fang, Z.-Y., Long, N., Ang, H.-Y., Zhang, Y., Fan, Y., & Xu, Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae185 · Cited by 20
“The Δ L cell was constructed using a CRISPR / Cas9-mediated knock-in technique ( 46 ).”
MethodCell-type-specific loops linked to RNA polymerase II elongation in human neural differentiation
Titus, K. R., Simándi, Z., Chandrashekar, H., Paquet, D., & Phillips‐Cremins, J. E. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100606 · Cited by 17
Self-citationRNA research for drug discovery: Recent advances and critical insight
Aja, P. M., Agu, P. C., Ogbu, C. O., Alum, E. U., Fasogbon, I. V., Musyoka, A. M., Ngwueche, W., Egwu, C. O., Tusubira, D., & Ross, K. (2025) · Gene · doi:10.1016/j.gene.2025.149342 · Cited by 17
Developmental history and application of CRISPR in human disease
Liang, P., Zhang, X., Chen, Y., & Huang, J. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.2963 · Cited by 19
“Tessier‐Lavigne Marc applied CRISPR to generate knock‐in of a specific mutation for Alzheimer's disease in human iPS cells.(150) They developed a method called CORRECT (Consecutive guide or reCas steps to erase CRISPR/Cas‐blocked targets) to improve HR accuracy.”
BackgroundMethodInfluentialSansbury, B. M., Wagner, A. M., Nitzan, E., Tarcic, G., & Kmiec, E. B. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0006 · Cited by 21
Han, F., Liu, C., Huang, J., Chen, J., Wei, C., Geng, X., Liu, Y., Han, D., & Li, M. (2019) · Brain Science Advances · doi:10.1177/2096595819896178 · Cited by 17
“, 2016 APP Swedish PS1 M146V (N = 1, n = 3) CRISPR / Cas9 NPCs, Cortical neurons ↑Aβ42/40 in dose-dependent manner of the mutation — [97]”
BackgroundGene Editing and Alzheimer's Disease: Is There Light at the End of the Tunnel?
Stepanichev, M. Y. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.00004 · Cited by 18
“Thus, the presence of the APP (Swe) mutation resulted in elevated Aβ production in neural precursors and neurons whereas the PSEN1 (M146V) mutation shifted the Aβ42:Aβ40 ratio to the prevalence of Aβ42 in iPSCs already and in the next stages of neuronal differentiation (Paquet et al., 2016).”
BackgroundHomology-Directed Repair in Zebrafish: Witchcraft and Wizardry?
Prill, K., & Dawson, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.595474 · Cited by 16
“Frontiers in Molecular Biosciences | www.frontiersin.org 1 December 2020 | Volume 7 | Article 595474 of the target nucleotide (Paquet et al., 2016; Boel et al., 2018; Burg et al., 2018; Bai et al., 2020).”
BackgroundUse of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs
Li, P. P., & Margolis, R. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-89312-2 · Cited by 18
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 16
“For example, the introduction of AD-associated mutations in iPSCs from healthy donors or correction of mutations in iPSCs from SAD or FAD donors [186] offers a promising opportunity to minimally study the implications of single-point mutations [187].”
Prime assembly with linear DNA donors enables large genomic insertions
Liu, B., Petti, A., Zhou, X., Cheng, H., Gao, J., Yee, M., Qiao, Y., Zhang, Y., Zhou, L. M., Wolfe, S. A., et al. (2026) · Nature · doi:10.1038/s41586-026-10460-4 · Cited by 21
“In the presence of a donor DNA, a DSB can be precisely repaired by HDR, but HDR is usually inefficient for large DNA insertions in primary cells and in vivo contexts 11–13 .”
Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems
Aquino‐Jarquín, G. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103793 · Cited by 15
Tackling mosaicism in gene edited livestock
Salvesen, H. A., Grupen, C. G., & McFarlane, G. R. (2024) · Frontiers in Animal Science · doi:10.3389/fanim.2024.1368155 · Cited by 22
Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Carraro, C., Montgomery, J. V., Klimmt, J., Paquet, D., Schultze, J. L., & Beyer, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1414886 · Cited by 20
“As already mentioned, these different in vitro platforms have particularly benefited from the introduction of hiPSC-derived cell cultures (Paquet et al., 2016).”
BackgroundSelf-citationRNA mimicry in post‐transcriptional regulation by aminoacyl tRNA synthetases
Levi, O., Garin, S., & Arava, Y. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1564 · Cited by 15
Han, C., He, X., Wang, J., Gao, L., Yang, G., Li, D., Wang, S., Chen, X., & Peng, Z. (2020) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2020.107486 · Cited by 15
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
Self-citationElton, T. S., Hernandez, V. A., Carvajal‐Moreno, J., Wang, X., Ipinmoroti, D., & Yalowich, J. C. (2022) · Cancers · doi:10.3390/cancers14133148 · Cited by 16
A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells
Ocaña, S. C., Yang, J. Y., Aushev, M., Schlossmacher, G., Bear, C. E., Hannan, N. R. F., Perkins, N. D., Rossant, J., Wong, A. P., & Gray, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210266 · Cited by 17
“Interestingly, it has been shown that the ‘distance effect’ can be predicted and utilised to control zygosity or tailor mutation incorporation by HDR [63].”
BackgroundMethodInfluentialChen, C., Ziobro, J. M., Robinson‐Cooper, L., Hodges, S. L., Chen, Y., Edokobi, N., López-Santiago, L. F., Habig, K., Moore, C., Minton, J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad283 · Cited by 17
Niccheri, F., Pecori, R., & Conticello, S. G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2524-y · Cited by 17
DMSO increases efficiency of genome editing at two non-coding loci
Stratigopoulos, G., Rosa, M. C. D., LeDuc, C. A., Leibel, R. L., & Doege, C. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198637 · Cited by 17
Production of CFTR-ΔF508 Rabbits
Yang, D., Liang, X., Pallas, B. D., Hoenerhoff, M. J., Ren, Z., Han, R., Zhang, J., Chen, Y. E., Jin, J., Sun, F., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.627666 · Cited by 17
“We reason that the most possible explanation to the differential outcome between sg01 and sg02, as suggested by an early report (Paquet et al., 2016), is the distances between the PAM (protospacer adjacent motif) location and the targeted mutation site.”
BackgroundImm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Precise and heritable gene targeting in rice using a sequential transformation strategy
Zhang, W., Wang, R., Kong, D., Peng, F., Chen, M., Zeng, W., Giaume, F., He, S., Zhang, H., Wang, Z., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100389 · Cited by 14
“It has been reported that SSNs can facilitate the efficiency of GT in many systems, including human stem cells.(7,17) The introduction of DSBs also increases the frequency of homologous recombination in plants.”
BackgroundWang, Z., Wang, L., Liu, W., Hu, D., Gao, Y., Ge, Q., Liu, X., Li, L., Wang, Y., Wang, S., et al. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101483 · Cited by 14
Li, Y., Weng, Y., Bai, D., Jia, Y., Liu, Y., Zhang, Y., Kou, X., Zhao, Y., Ruan, J., Chen, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18391-y · Cited by 16
Fu, X., Lui, K. N.-C., Tang, C. S.-M., Ng, R. K., Lai, F. P.-L., Lau, S.-T., Li, Z., García-Barceló, M.-M., Sham, P. C., Tam, P. K. H., et al. (2020) · Genome Research · doi:10.1101/gr.264473.120 · Cited by 15
Mac, T. T., Fauquier, T., Jullien, N., Romanet, P., Etchevers, H., Barlier, A., Castinetti, F., & Brue, T. C. (2023) · eLife · doi:10.7554/elife.90875.3 · Cited by 17
Hou, Y., Ureña-Bailén, G., Gol, T. M., Gratz, P. G., Gratz, H. P., Roig‐Merino, A., Antony, J. S., Lamsfus‐Calle, A., Daniel-Moreno, A., Handgretinger, R., et al. (2022) · Genes · doi:10.3390/genes13122348 · Cited by 14
“459A) to avoid r cutting and improve the editing efficiency [31,32].”
BackgroundKanke, K. L., Rayner, R. E., Bozik, J., Abel, E., Venugopalan, A., Suu, M., Nouri, R., Stack, J. T., Guo, G., Vetter, T. A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1069 · Cited by 14
Neggers, J. E., Jacquemyn, M., Dierckx, T., Kleinstiver, B. P., Thibaut, H. J., & Daelemans, D. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.025 · Cited by 13
Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing Tools
Kim, U., Kim, N., & Shin, H. Y. (2020) · Cells · doi:10.3390/cells9122572 · Cited by 13
“Unlike base editors, the prime editor can generate both transition (purine to purine; C↔T or G↔A) and transversion (purine to pyrimidine; A or G to T or C) mutations [45,46].”
BackgroundCRISPR/Cas9 Genome Editing Approaches for Psychiatric Research
Gutiérrez-Rodríguez, A., Cruz-Fuentes, C. S., Mendoza, A. D. G., & Nicolini, H. (2023) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2913 · Cited by 20
Multiple gene modifications of pigs for overcoming obstacles of xenotransplantation
Wu, H., Lian, M., & Lai, L. (2023) · National Science Open · doi:10.1360/nso/20230030 · Cited by 14
“…expression level of foreign genes, such as the CRISPR-associated transposon [114–118], homology-independent targeted integration (HITI) [119–122], single-strand oligonucleotide (ssODN) mediated seamless knock-in [87,123], and prime editor-mediated insertion of small DNA fragments [111,124,125].”
BackgroundFarrell, S. A., Sodhi, S., Marshall, C. R., Guerin, A. A., Slavotinek, A. M., Paton, T., Chong, K., Sirkin, W. L., Scherer, S. W., Bérubé‐Simard, F., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38354 · Cited by 13
“optimal by others (Cong et al., 2013; Paquet et al., 2016), we thus conclude that this region of the mouse Hlx locus cannot be easily manipulated by homologous recombination.”
BackgroundImportant advances in Alzheimer’s disease from the use of induced pluripotent stem cells
Majolo, F., Marinowic, D. R., Machado, D. C., & da Costa, J. C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0501-5 · Cited by 17
Genetically Encoded Tools for Research of Cell Signaling and Metabolism under Brain Hypoxia
Kostyuk, A. I., Kokova, A. D., Podgorny, O. V., Kelmanson, I. V., Fetisova, E. S., Belousov, V. V., & Bilan, D. S. (2020) · Antioxidants · doi:10.3390/antiox9060516 · Cited by 13
Generation and validation of homozygous fluorescent knock-in cells using CRISPR/Cas9 genome editingPreprint
Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/188847 · Cited by 13
Carrington, B., Ramanagoudr‐Bhojappa, R., Bresciani, E., Han, T., & Sood, R. B. (2022) · BMC Genomics · doi:10.1186/s12864-022-08971-1 · Cited by 12
“In addition, ssODNs were designed with PAM site modifications known as CRISPR/Cas9blocking mutations [65] to prevent recutting after HDR.”
MethodNanoparticle Carriers: A New Era of Precise CRISPR/Cas9 Gene Editing
Sharma, B., Chauhan, I., Kumar, G., Bhardwaj, K., & Tiwari, R. K. (2024) · MicroRNA · doi:10.2174/0122115366319848241022092805 · Cited by 12
Tekel, S. J., Brookhouser, N., Standage-Beier, K., Wang, X., & Brafman, D. A. (2021) · Nature Protocols · doi:10.1038/s41596-021-00552-y · Cited by 12
3R measures in facilities for the production of genetically modified rodents
Zevnik, B., Jerchow, B., & Buch, T. (2022) · Lab Animal · doi:10.1038/s41684-022-00978-1 · Cited by 14
Defining and targeting patterns of T cell dysfunction in inborn errors of immunity
Campos, J. S., & Henrickson, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932715 · Cited by 12
Lui, K. N.-C., & Ngan, E. (2022) · Cells · doi:10.3390/cells11213428 · Cited by 13
Sarmah, H., Sawada, A., Hwang, Y., Miura, A., Shimamura, Y., Tanaka, J., Yamada, K., & Mori, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1070560 · Cited by 13
“The engineered human iPSC-derived organoid transplantation into the defective tissue niche, particularly in the immune-privilege niche such as subrenal regions, testes, eyes, liver, and brain, holds great promise for evaluating stemness and mouse disease modeling as a next-generation personalized medicine (Harrison et…”
BackgroundRecent Progress in Genetics and Epigenetics Research on Diabetic Nephropathy in Malaysia
Seman, N. A., & Othman, S. H. (2023) · Journal of Diabetes Research · doi:10.1155/2023/9053580 · Cited by 12
“The nonspecific insertions, deletions, or other mutations (indels) could be reversed using the CRISP technique [47], and the function of the genetic variants in the disease could be further evaluated.”
MethodThe Role of Noncoding RNAs in Neurodevelopmental Disorders: The Case of Rett Syndrome
Obiols-Guardia, A., & Guil, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_2 · Cited by 13
Mishima, T., Fujioka, S., Fukae, J., Yuasa‐Kawada, J., & Tsuboi, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123870 · Cited by 13
“A recent study reported a new CRISPR-based methodology, termed CORRECT, which enables accurate HDR-dependent introduction of intended mutations in a mono- or bi-allelic manner [80].”
BackgroundQuality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene
Hanss, Z., Boussaad, I., Jarazo, J., Schwamborn, J. C., & Krüger, R. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01297 · Cited by 12
Liu, X., Li, Y., & Bai, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821477-0.00006-4 · Cited by 12
Controlling homology-directed repair outcomes in human stem cells with dCas9Preprint
Skarnes, W. C., Ning, G., Giansiracusa, S., Cruz, A. S., Blauwendraat, C., Saavedra, B., Holden, K., Cookson, M. R., Ward, M. E., & McDonough, J. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472942 · Cited by 12
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment
Tripathi, S., Sharma, Y., Rane, R. A., & Kumar, D. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273283786240408034408 · Cited by 12
Rong, X., Yao, X., Fang, H., Saji, J., Qian, Y., Gu, J.-X., Yang, M., Peng, W., Liu, C.-R., Chen, B., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01869-6 · Cited by 14
“The isogenic human iPSC (hiPSC) lines carrying APPswe mutations, and the engineered 7889SA iPSC line (WT control) were obtained from previous studies [34, 35].”
Uncovering Natural Longevity Alleles from Intercrossed Pools of Aging Fission Yeast Cells
Ellis, D., Mustonen, V., Rodríguez‐López, M., Rallis, C., Małecki, M., Jeffares, D. C., & Bähler, J. (2018) · Genetics · doi:10.1534/genetics.118.301262 · Cited by 12
“However, this approach is only feasible if either the Protospacer Adjacent Motif (PAM), or the region immediately upstream, are altered after HR (Paquet et al. 2016).”
BackgroundSuzuki, T., Tsukumo, Y., Furihata, C., Naito, M., & Kohara, A. (2020) · Genes and Environment · doi:10.1186/s41021-020-0147-2 · Cited by 11
A Simple and Efficient CRISPR Technique for Protein Tagging
Zeng, F., Beck, V., Schuierer, S., Garnier, I., Manneville, C., Agarinis, C., Morelli, L., Quinn, L., Knehr, J., Roma, G., et al. (2020) · Cells · doi:10.3390/cells9122618 · Cited by 11
“For example, knock-in can be efficient within ± 10 bp around DSB sites for HDR-based protocols [22]; however, it can only happen at DSB sites for HiTag.”
BackgroundGene editing technology: Towards precision medicine in inherited retinal diseases
Ballios, B. G., Pierce, E. A., & Huckfeldt, R. M. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1887903 · Cited by 13
Finney, M., Romanowski, J. S., & Adelman, Z. N. (2022) · Virology Journal · doi:10.1186/s12985-022-01859-2 · Cited by 13
Long non‑coding RNAs in gallbladder cancer: From mechanisms to therapeutic opportunities (Review)
He, Y., Du, X., Fan, Y., Yan, C., Chen, M., Han, L., & Sun, J. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5604 · Cited by 11
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.